NL-OMON31864CompletedNot Applicable
A human phase 0, microdose pharmacokinetic study of [14C]-Org 201745-0, [14C]-Org 244378-0 and [14C]-Org 245021-0 in post-menopausal female volunteers - [14C]-Org 201745, [14C]-Org 244378 and [14C]-Org 245021 Microdosing Study
Organon Nederland BV0 sites18 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 18
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •45-70 years of age
- •amenorrhoe for 18 months
Exclusion Criteria
- •history of significant disease
Investigators
Similar Trials
Completed
Phase 1
Testing IMM60 in combination with pembrolizumab in melanoma and non-small cell lung cancerCancerISRCTN80472712niversity of Oxford15
Active, not recruiting
Phase 1
A scientific experiment on patients, to evaluate the effects of various treatments used for bonemarrowcancer, on cells and genes.EUCTR2011-003791-37-DKDepartment of Haematology, Aalborg University Hospital21
Recruiting
Not Applicable
First-in-human Phase I dose escalation study assessing safety, tolerability and preliminary efficacy of immunomodulatory nanoparticlesNL-OMON52685Tumor Immunology15
Active, not recruiting
Phase 1
A Phase 1, First-in-Human, Dose Escalation Study of the JNJ-75348780 Bispecific Antibody Targeting CD3 and CD22 in Participants with NHL and CRelapsed/refractory B-cell Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)CTIS2023-504403-92-00Janssen - Cilag International200
Recruiting
Phase 1
Phase I study of optimal dose and pharmacokinetics of a Uracil/Tegafur (UFT) plus oral leucovorin regimen after liver resection for colorectal liver metastasisiver resection for liver metastasis of colorectal cancerJPRN-UMIN000021146Oita university, faculty of medicine, department gastroenterology and pediatric surgery18